Buchumschlag

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chung‐Ting Kuo, Yi‐Chen Wu, Ji‐Min Li, Tz‐Chuen Ju, Tien‐Sheng Tseng
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Chemical Biology & Drug Design
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
von: Hualiang Shen, et al.
Veröffentlicht: (2025)

Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone–Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity
von: Jovana S. Marjanović, et al.
Veröffentlicht: (2024)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
von: Gözde Sayar, et al.
Veröffentlicht: (2026)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
von: Shiying Zhang, et al.
Veröffentlicht: (2025)

Integrative Experimental Paradigm of Oxadiazole–Schiff Base Hybrids: Pharmacophore‐Driven Docking Simulations and DFT Insights Toward Antidiabetic Therapeutic Discovery
von: Aisha Bibi, et al.
Veröffentlicht: (2026)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
von: Vijaykumar D. Nimbarte, et al.
Veröffentlicht: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
von: Shreetama Bandyopadhayaya, et al.
Veröffentlicht: (2025)

Synthesis and Molecular Modeling Studies of New Thiadiazole‐Thiophene Compounds as Potent Antimicrobial Agents
von: Nuha M. Halawani, et al.
Veröffentlicht: (2025)

Identification and Biological Evaluation of ( 4 H ‐Thieno[3,2‐ b ]indol‐3‐yl)methanol as a Tumoricidal Scaffold for an Antineoplastic Agent
von: Shi‐Hong Zhuang, et al.
Veröffentlicht: (2025)

Molecular Mechanism of Dexmedetomidine in Alzheimer's Disease: Machine Learning Identifies RGS7 as a Key Therapeutic Targe
von: Yangliang Yang, et al.
Veröffentlicht: (2025)

Synthesis and SAR investigation of biphenylaminoquinoline derivatives with benzyloxy substituents as promising anticancer agents
von: Yu‐Chieh Wu, et al.
Veröffentlicht: (2024)

Biochemical and Structural Studies of Protein Tyrosine Phosphatase PTP‐PEST (PTPN12) in Search of Small Molecule Inhibitors
von: Delna Johnson, et al.
Veröffentlicht: (2025)

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases
von: Xiuyi Ou, et al.
Veröffentlicht: (2026)

Identification of Autophagy‐Associated Molecular Signatures in Osteoarthritis Revealed by Integrative Multi‐Omics and Experimental Validation
von: Xiaoqing Wang, et al.
Veröffentlicht: (2026)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
von: Vladislav Lobanov, et al.
Veröffentlicht: (2025)

Integrated Virtual Screening and Molecular Dynamics Simulation Study to Discover Potential Activators of γ‐Aminobutyric Acid B Receptor 1 for Therapeutic Targeting of Neurodegenerative Diseases
von: Asfiya, et al.
Veröffentlicht: (2026)

Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
von: Aamir Mehmood, et al.
Veröffentlicht: (2024)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
von: Nurul Alam Inayatsyah, et al.
Veröffentlicht: (2024)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
von: Huiping Li, et al.
Veröffentlicht: (2024)

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents
von: Pınar Poyraz Yılmaz, et al.
Veröffentlicht: (2025)

Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy
von: Fangfang Jiao, et al.
Veröffentlicht: (2025)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
von: Yihao Liu, et al.
Veröffentlicht: (2026)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
von: Jiayi Shen, et al.
Veröffentlicht: (2024)

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
von: Timoteo Delgado‐Maldonado, et al.
Veröffentlicht: (2025)

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
von: Tingting Zhang, et al.
Veröffentlicht: (2026)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
von: Jiayi Shen, et al.
Veröffentlicht: (2025)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
von: Yi‐Fan Zhang, et al.
Veröffentlicht: (2024)

In Vitro Cytotoxicity and Mechanistic Investigation of Quinazolin‐4(1H)‐One Linked Coumarin as a Potent Anticancer Agent
von: Dinesh Singla, et al.
Veröffentlicht: (2024)

Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity
von: Bruno A. De Oliveira, et al.
Veröffentlicht: (2025)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
von: Ankit Kumar Singh, et al.
Veröffentlicht: (2025)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
von: Jingting Zeng, et al.
Veröffentlicht: (2025)

Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents
von: Ayoub Boualli, et al.
Veröffentlicht: (2025)

Guided Ensemble Stacking Method for Predicting Biological Activities of Compounds
von: Azar Shamloo, et al.
Veröffentlicht: (2025)

Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches
von: Yulong Zhao, et al.
Veröffentlicht: (2024)

Spacered With Tetrazole Oleanolic and Ursolic Indolo‐Acids Are Strong Inhibitors of α‐Glucosidase
von: Anastasiya V. Petrova, et al.
Veröffentlicht: (2025)

Hepatocellular Carcinoma Cells in Humans Exhibit Resistance to Suberoylanilide Hydroxamic Acid (SAHA) Owing to the Diminished Level of Hsa‐miR‐125a‐5p
von: Shih‐Wen Kao, et al.
Veröffentlicht: (2025)

Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis: A Computational and Experimental Study
von: Mariana Sant’Anna Pereira Nicolau, et al.
Veröffentlicht: (2025)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
von: Rui Pereira, et al.
Veröffentlicht: (2026)

Therapeutic Potential of 6‐Gingerol in Glioma: Mechanistic Insights and Experimental Validation
von: Shan Miao, et al.
Veröffentlicht: (2025)

The Therapeutic Effect and Mechanism of Vismodegib on COPD : Focusing on NETs and Macrophage Polarization
von: Ming Wu, et al.
Veröffentlicht: (2026)